Title:
ＧＬＰ−１及び抗ＩＬ−２１を使用した１型糖尿病の治療
Document Type and Number:
Japanese Patent JP6672175
Kind Code:
B2
Abstract:
The present invention relates to use of a GLP-1 agonist and an anti-IL-2 antibody in treatment and/or prevention of type 1 diabetes.
Inventors:
Ken Copierters
Matthias von Herat
Tamer bohsarian
Matthias von Herat
Tamer bohsarian
Application Number:
JP2016566689A
Publication Date:
March 25, 2020
Filing Date:
May 05, 2015
Export Citation:
Assignee:
Novo Nordisk Ar/S
International Classes:
A61K38/26; A61K39/395; A61P3/10
Domestic Patent References:
| JP2011506422A | ||||
| JP2000500505A |
Foreign References:
| WO2005023291A1 | ||||
| WO2012164021A1 |
Other References:
Diabetes,2009年,Vol.58,No.5,pp.1144-1155
Clinical Immunology,2013年,Vol.149,No.3,pp.317-323
Clinical Immunology,2013年,Vol.149,No.3,pp.317-323
Attorney, Agent or Firm:
Yasuhiko Murayama
Shinya Mitsuhiro
Tatsuhiko Abe
Shinya Mitsuhiro
Tatsuhiko Abe